|
TSPAN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54249999995137E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57285999999868E-05 |
| Normal-vs-Stage2 |
4.95400054312256E-10 |
| Normal-vs-Stage3 |
1.93411953119949E-12 |
| Normal-vs-Stage4 |
1.60371999999853E-05 |
| Stage1-vs-Stage2 |
3.085600E-01 |
| Stage1-vs-Stage3 |
3.052400E-01 |
| Stage1-vs-Stage4 |
8.182200E-01 |
| Stage2-vs-Stage3 |
9.031600E-01 |
| Stage2-vs-Stage4 |
5.039000E-01 |
| Stage3-vs-Stage4 |
4.829200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.24369999999708E-05 |
| Normal-vs-AfricanAmerican |
1.78674999999906E-05 |
| Normal-vs-Asian |
1.09230000000515E-06 |
| Caucasian-vs-AfricanAmerican |
9.543600E-01 |
| Caucasian-vs-Asian |
2.451000E-01 |
| AfricanAmerican-vs-Asian |
1.661970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01169999999762E-06 |
| Normal-vs-Female |
6.422700E-03 |
| Male-vs-Female |
1.894220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.817200E-01 |
| Normal-vs-Extreme_Weight |
5.964200E-02 |
| Normal-vs-Obese |
4.27360002941413E-09 |
| Normal-vs-Extreme_Obese |
6.576500E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.927400E-01 |
| Normal_Weight-vs-Obese |
3.464800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.764400E-01 |
| Extreme_Weight-vs-Obese |
6.187200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.299200E-01 |
| Obese-vs-Extreme_Obese |
9.299600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.136500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.94300139813686E-11 |
| Normal-vs-Age(61-80Yrs) |
1.129870E-02 |
| Normal-vs-Age(81-100Yrs) |
1.62558855265615E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.252800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.910800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.761800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.093200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.734100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.629800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
3.175800E-02 |
| Normal-VS-KIRP CIMP |
5.987400E-01 |
| Normal-VS-Unclassified PRCC |
3.33066907387547E-16 |
| Type1 PRCC-VS-Type2 PRCC |
1.199980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.116200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.088400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.464200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.585650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.404270E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.17309997458437E-10 |
| Normal-vs-N2 |
3.654800E-01 |
| N0-vs-N1 |
9.266300E-02 |
| N0-vs-N2 |
3.479000E-01 |
| N1-vs-N2 |
5.111200E-01 |
|
|
